Molecular Partners Ag (MOLN) Common Equity (2020 - 2026)
Molecular Partners Ag's Common Equity came in at $74.07 million for Q2 2026, down 42.5% from $128.84 million a year earlier and down 15.3% from the prior quarter.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Molecular Partners Ag's Common Equity was $96.89 million, down 39.8% from FY2024.
- Common Equity has declined in each of the last three years, with a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
- Going back by year, Common Equity was $161 million in FY2024 (-18.0%), $196.44 million in FY2023 (-20.3%), $246.56 million in FY2022 (+110.0%) and $117.42 million in FY2021 (+2.7%).
- The Q2 2026 figure represents the lowest quarterly Common Equity in data going back to Q4 2020.
- Year-over-year, Common Equity has declined for 14 consecutive quarters, with an average decline of 30.3% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q4 2022 (growth of 109.8%), and the weakest in Q2 2026 (a decline of 42.5%).
- Business Quant data shows MOLN's Common Equity at $87.41 million (Q1 2026), $100.51 million (Q4 2025) and $119.42 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Molecular Partners Ag | 138.65 Mn | -292.59 Mn | - | 72.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.49 Mn |
| Mar 31, 2026 | 85.58 Mn |
| Dec 31, 2025 | 101.47 Mn |
| Sep 30, 2025 | 119.83 Mn |
| Jun 30, 2025 | 133.62 Mn |
| Mar 31, 2025 | 145.53 Mn |
| Dec 31, 2024 | 156.81 Mn |
| Sep 30, 2024 | 165.11 Mn |
| Jun 30, 2024 | 173.14 Mn |
| Mar 31, 2024 | 187.05 Mn |
| Dec 31, 2023 | 209.20 Mn |
| Sep 30, 2023 | 214.49 Mn |
| Jun 30, 2023 | 229.08 Mn |
| Mar 31, 2023 | 243.23 Mn |
| Dec 31, 2022 | 254.83 Mn |
| Sep 30, 2022 | 257.90 Mn |
| Mar 31, 2022 | 286.57 Mn |
| Dec 31, 2021 | 117.42 Mn |
| Sep 30, 2021 | 133.18 Mn |
| Dec 31, 2020 | 121.62 Mn |
API Access
Molecular Partners Ag Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();